Multimodal Glucose Prediction in Type 2 Diabetes
NCT: NCT07633171 · NOT_YET_RECRUITING
Brief Summary
The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuous Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-time glucose prediction and personalized diabetes management for patients with Type 2 diabetes (T2D), delivered via mobile apps and digital health tools.
Frequently Asked Questions
What is Multimodal Glucose Prediction in Type 2 Diabetes?
Multimodal Glucose Prediction in Type 2 Diabetes is a clinical trial registered under NCT07633171. Current status: NOT_YET_RECRUITING.
What is the status of NCT07633171?
The current status of NCT07633171 (Multimodal Glucose Prediction in Type 2 Diabetes) is: NOT_YET_RECRUITING.
When did Multimodal Glucose Prediction in Type 2 Diabetes start?
Multimodal Glucose Prediction in Type 2 Diabetes started on 2026-06-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.